NHI.no
Annonse
Informasjon

Kneleddsartrose

Knærne er sammen med hofteleddene de leddene i kroppen som belastes mest gjennom livet. Slitasjeforandringer i brusk eller ben i kneleddene er en hyppig tilstand som kalles kneleddsartrose. Behandlingen er opplæring og informasjon om tilstanden, vektreduksjon ved overvekt eller fedme, tilpasset fysisk aktivitet og øvelser livet ut, eventuelt smertestillende medisiner og avlastende tiltak. Hos noen få pasienter kan det være nødvendig med proteseoperasjon, der det vil settes inn et kunstig kneledd.

Fotoet viser en eldre kvinne ute på en grusvei i sola, ikledd treningsklær. Utsnittet viser henne forfra, fra magen til ankelen. Hun holder sitt høyre kne med sin høyre hånd. Området rundt kneet er farget rødt.
Artrose i kneleddet kalles det når leddbrusk eller bein i kneleddet er endret slik at overflatene ikke lenger er glatte og symmetriske. Forekomsten øker med alderen. Hos en del personer medfører forandringene symptomer, hos andre ikke. Foto: Colourbox

Sist oppdatert:

13. mars 2024

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Kneleddsartrose . Referanselisten for dette dokumentet vises nedenfor

  1. Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185-99. Epub 2013 Jan 20. PMID: 23337796 PubMed
  2. Michael JW, Schlüter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010 Mar;107(9):152-62. Erratum in: Dtsch Arztebl Int. 2010 Apr;107(16):294. PMID: 20305774 PubMed
  3. March L. Epidemiology and risk factors for osteoarthritis. UpToDate. Last updated Oct 05, 2023. Site read March 11, 2024. www.uptodate.com
  4. Wallace IJ, Worthington S, Felson DT3, et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017; 114: 9332-6. pmid:28808025 PubMed
  5. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023. doi:10.1016/S2665-9913(23)00163-7 DOI
  6. Sharma L. Osteoarthritis of the Knee. N Engl J Med. 2021 Jan 7;384(1):51-59. PMID: 33406330. PubMed
  7. Furnes O, Hallan G, Hole R, et al. Årsrapport for 2022 med plan for forbedringstiltak. Nasjonalt register for leddproteser. Utgitt 15. juni 2023, Haukeland universitetssykehus. www.kvalitetsregistre.no
  8. Berteau JP. Knee Pain from Osteoarthritis: Pathogenesis, Risk Factors, and Recent Evidence on Physical Therapy Interventions. J Clin Med. 2022;11(12):3252. Published 2022 Jun 7. PMID: 35743322 PubMed
  9. Palmer KT. Occupational activities and osteoarthritis of the knee. Br Med Bull. 2012 Jun;102:147-70. doi: 10.1093/bmb/lds012. Epub 2012 Apr 26. PMID: 22544778 PubMed
  10. National Institute for Health and Care Excellence (NICE), UK. Osteoarthritis in over 16s: diagnosis and management. NICE guideline [NG 226], published: 19 October 2022 www.nice.org.uk
  11. Wu CW, Morrell MR, Heinze E, et al.. Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores. Semin Arthritis Rheum. 2005 Dec;35(3):197-201. PMID: 16325660 PubMed
  12. Menkes CJ. Radiographic criteria for classification of osteoarthritis. J Rheumatol Suppl. 1991 Feb;27:13-5. PMID: 2027113. PubMed
  13. Sagsveen M. Lite samsvar mellom knesmerte og MR-funn. Tidsskr Nor Legeforen 2009. 129:1082. doi: 10.4045/tidsskr.09.0539. tidsskriftet.no
  14. The Royal Australian College of General Practitioners. Guideline for the management of knee and hip osteoarthritis. 2nd edn. East Melbourne, Vic: RACGP, 2018. www.racgp.org.au
  15. Østerås N, Moseng T. Oppsummering av behandlingsanbefalinger ved kne- og hofteartrose. For helsepersonell. Diakonhjemmet sykehus. Publisert januar 2024. www.diakonhjemmetsykehus.no
  16. Bjordal JM, Klovning A, Ljunggren AE et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2006, doi: 10.1016/j.ejpain.2006.02.013.
  17. Bannuru RR, Schmid CH, Kent DM, et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: A systematic review and network meta-analysis. Ann Intern Med 2015; 162: 46-54. doi:10.7326/M14-1231 DOI
  18. Juhl C, Christensen R, Roos EM, et al. Impact of exercise type and dose on pain and disability in knee osteoarthritis: A systematic review and meta-regression analysis of randomized controlled trials. Arthritis Rheumatol 2014; 66: 622–636. doi: 10.1002/art.38290 DOI
  19. Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee. Cochrane Database Syst Rev. 2015 Jan 9;1:CD004376. Cochrane (DOI)
  20. Amin S, Baker K, Niu J, et al. Quadriceps strength and the risk of cartilage loss and symptom progression in knee osteoarthritis. Arthritis Rheum 2009; 60: 189-98. PubMed
  21. Torstensen TA, Østerås H, et al. High- versus low-dose exercise therapy for knee osteoarthritis: A randomized controlled multicenter trial. Ann Intern Med 2023. Ann Intern Med 2023. PMID: 36689746 PubMed
  22. American Academy of Orthopaedic Surgeons Management of Osteoarthritis of the Knee (Non-Arthroplasty). Evidence-Based Clinical Practice Guideline. Published 08/30/2021 www.aaos.org
  23. da Costa BR, Pereira TV, Saadat P, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021 Oct 12;375:n2321. PMID: 34642179 PubMed
  24. Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008 Oct 2;9:132. PMID: 18831740 PubMed
  25. da Costa BR, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 2017. PMID: 28699595 PubMed
  26. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589. Epub 2019 Jul 3. PMID: 31278997 PubMed
  27. Gunter BR, Butler KA, Wallace RL, et al. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. J Clin Pharm Ther 2017; 42: 27-38. pmid:28019014 PubMed
  28. Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 2015; 350: h1225. doi:10.1136/bmj.h1225 DOI
  29. McAlindon TE, LaValley MP, Harvey WF, et al . Effect om intra-articular triamcinolone vs saline on knee cartilage volumen and pain in patients with knee osteoarthritis. A randomized clinical trial. JAMA 2017; 317: 1967-75. doi:10.1001/jama.2017.5283 DOI
  30. Ferreira GE, Abdel-Shaheed C, Underwood M, et al. Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews. BMJ 2023; 380: e072415. pmid:36725015 PubMed
  31. Lisi C, Perotti C, Scudeller L, et al. Treatment of knee osteoarthritis: platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial. Clin Rehabil. 2018; 32: 330-9. PMID: 28783969 PubMed
  32. Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013; 41: 356-64. pmid:23299850 PubMed
  33. Le ADK, Enweze L, DeBaun MR, Dragoo JL. Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr Rev Musculoskelet Med. 2018; 11: 624-34. pmid:30353479 PubMed
  34. Bennell KL, Paterson KL, Metcalf BR, et al. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis The RESTORE Randomized Clinical Trial. JAMA 2021; 326: 2021-30. pmid:34812863 PubMed
  35. Sit RWS, Wu RWK, Rabago D, et al. Efficacy of Intra-Articular Hypertonic Dextrose (Prolotherapy) for Knee Osteoarthritis: A Randomized Controlled Trial. Ann Fam Med. 2020 May;18(3):235-242. doi: 10.1370/afm.2520. PMID: 32393559 PubMed
  36. Pramhas S, Thalhammer T, Terner S, et al. Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Lancet Reg Health Eur 2023; 35: 100777. pmid:38033459 PubMed
  37. Beard DJ, Davies LJ, Cook JA, et al. The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial. Lancet 2019. pmid:31326135 PubMed
  38. Price AJ, Alvand A, Troelsen A, Katz JN, Hooper G, Gray A, Carr A, Beard D. Knee replacement. Lancet. 2018 Nov 3;392(10158):1672-1682. PMID: 30496082 PubMed
  39. Shan L, Shan B, Suzuki A, et al. Intermediate and long-term quality of life after total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Am. 2015;97(2):156-68. PMID: 25609443 PubMed
  40. Lindberg MF, Miaskowski C, Rustøen T, Rosseland LA, Cooper BA, Lerdal A. Factors that can predict pain with walking, 12 months after total knee arthroplasty. Acta Orthop. 2016; 87: 600-6. PMID: 27658970 PubMed
  41. Fortier LM, Rockov ZA, Chen AF, Rajaee SS. Activity Recommendations After Total Hip and Total Knee Arthroplasty. J Bone Joint Surg Am. 2021 Mar 3;103(5):446-455. doi: 10.2106/JBJS.20.00983. PMID: 33337819 PubMed
  42. Martin GM. Complications of total knee arthroplasty. UpToDate. Topic last updated Mar 18, 2020. Site visited 28.09.2021. www.uptodate.com
  43. van den Driest JJ, Schiphof D, Koffeman AR, et al. No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster-Randomized Trial. Arthritis Rheumatol 2022; 74: 818-828. pmid:34989159 PubMed
Annonse
Annonse